Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9036)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 14, 2022 (publication date) through May 20, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Kudryavtseva A, Krasnov G. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World J Gastroenterol 2022; 28(10): 1067-1077 [PMID: 35431497 DOI: 10.3748/wjg.v28.i10.1067] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i10/1067.htm |
| Number | Citing Articles |
| 1 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Ekaterina Vasilieva, Yury Zharikov, Andrey Suslov, Yana Letyagina, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Epidemiology of small intestinal bacterial overgrowth. World Journal of Gastroenterology 2023; 29(22): 3400-3421 doi: 10.3748/wjg.v29.i22.3400
Abstract(1168) |
Core Tip(777) |
Full Article(HTML)(23162)
|
Full Article with Cover (PDF)-1256K(218)
|
Full Article (Word)-195K(43)
|
Audio-930K(15)
|
Peer-Review Report-241K(102)
|
Answering Reviewers-118K(109)
|
Full Article (PDF)-605K(1020)
|
Full Article (XML)-330K(115)
|
Times Cited (38)
|
Total Visits (29287)
|
Open
|
| 2 |
Irina Efremova, Roman Maslennikov, Aliya Alieva, Elena Poluektova, Vladimir Ivashkin. Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis. Microorganisms 2023; 11(4): 1017 doi: 10.3390/microorganisms11041017
|
| 3 |
Paulina Roszkowska, Emilia Klimczak, Ewa Ostrycharz, Aleksandra Rączka, Iwona Wojciechowska-Koszko, Andrzej Dybus, Yeong-Hsiang Cheng, Yu-Hsiang Yu, Szymon Mazgaj, Beata Hukowska-Szematowicz. Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases—Current State of Knowledge. Biomedicines 2024; 12(5): 1030 doi: 10.3390/biomedicines12051030
|
| 4 |
Qi-Qi Xie, Jia-Feng Wang, Yang-Fen Zhang, Dong-Hui Xu, Bo Zhou, Ting-Hui Li, Zhi-Peng Li. Glucose substrate in the hydrogen breath test for gut microbiota determination: A recommended noninvasive test. World Journal of Clinical Cases 2022; 10(26): 9536-9538 doi: 10.12998/wjcc.v10.i26.9536
|
| 5 |
André Pontes-Silva, André Luiz Lopes, Erika da Silva Maciel, Fernando Rodrigues Peixoto Quaresma, Almir Vieira Dibai-Filho. Human metabolism and body composition: prospects for novel studies. Nutrition Reviews 2023; 82(1): 5 doi: 10.1093/nutrit/nuad040
|
| 6 |
Irina Efremova, Roman Maslennikov, Oleg Medvedev, Anna Kudryavtseva, Anastasia Avdeeva, George Krasnov, Filipp Romanikhin, Mikhail Diatroptov, Maria Fedorova, Elena Poluektova, Anna Levshina, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis. Microorganisms 2024; 12(3): 463 doi: 10.3390/microorganisms12030463
|
| 7 |
Siyuan Sun, Guangheng Zhang, Shimeng Lv, Jinhui Sun. Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1407991
|
| 8 |
Eden Sharabi, Ali Rezaie. Small Intestinal Bacterial Overgrowth. Current Infectious Disease Reports 2024; 26(11): 227 doi: 10.1007/s11908-024-00847-7
|
| 9 |
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
Abstract(857) |
Core Tip(787) |
Full Article(HTML)(4598)
|
Full Article with Cover (PDF)-2077K(143)
|
Full Article (Word)-351K(67)
|
Audio-395K(24)
|
Peer-Review Report-291K(100)
|
Answering Reviewers-97K(109)
|
Full Article (PDF)-967K(360)
|
Full Article (XML)-396K(111)
|
Times Cited (15)
|
Total Visits (10015)
|
Open
|
| 10 |
Dmitry Victorovich Garbuzenko. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis. World Journal of Hepatology 2023; 15(4): 525-537 doi: 10.4254/wjh.v15.i4.525
|
| 11 |
Ya-Nan Li, Na-Ling Kang, Jia-Ji Jiang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng, Fei Wang. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes. World Journal of Gastroenterology 2022; 28(35): 5188-5202 doi: 10.3748/wjg.v28.i35.5188
|
| 12 |
Shiqi Zhang, Pinglan Li, Suwon Lee, Yu Wang, Chunming Tan, Nan Shang.
Weizmannia coagulans: an Ideal Probiotic for Gut Health
. Food Science and Human Wellness 2023; : 1 doi: 10.26599/FSHW.2022.9250002
|
| 13 |
Irina Efremova, Roman Maslennikov, Maria Zharkova, Elena Poluektova, Nona Benuni, Aleksandr Kotusov, Tatyana Demina, Aleksandra Ivleva, Farida Adzhieva, Taisiya Krylova, Vladimir Ivashkin. Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study. Journal of Clinical Medicine 2024; 13(3): 919 doi: 10.3390/jcm13030919
|
| 14 |
D.V. Garbuzenko. Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential. Dokazatel'naya gastroenterologiya 2022; 11(4): 65 doi: 10.17116/dokgastro20221104165
|
| 15 |
Elias Xirouchakis, Alexandros Pelekanos, Spyridon Xirouchakis, Hariklia Kranidioti, Spilios Manolakopoulos. A Systematic Review of Microbiota in Cirrhosis: A Change Towards a More Pathogenic Predisposition. International Journal of Molecular Sciences 2025; 26(2): 527 doi: 10.3390/ijms26020527
|
| 16 |
Aneta Kiecka, Marian Szczepanik. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics. Pharmacological Reports 2023; 75(4): 791 doi: 10.1007/s43440-023-00489-x
|
| 17 |
Yu. N. Alekhin, V. S. Ponamarev, O. S. Popova. Pathogenetic bases of the combined use of drugs from the groups of hepatoprotectors and phytosorbents. International Journal of Veterinary Medicine 2022; (2): 47 doi: 10.52419/issn2072-2419.2022.2.47
|
| 18 |
Xue Li, Xinyi Xu, Sian Tao, Yue Su, Li Wen, Dong Wang, Jibin Liu, Quansheng Feng. Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1347120
|